Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
The global coagulation analyzers market, by product type (Analyzers (Clinical Laboratory Analyzers, Point of Care Analyzers) and Consumables (Reagents & Kits, Point-of-care strips), by test type (Activated Partial Thromboplastin Time Test, Prothrombin Time Test, D-Dimer Test, Fibrinogen Test, and Other Coagulation Tests), and by end-user (Hospitals, Diagnostic Laboratories, Research Institutes, and Others), was evaluated at US$ 2,481.78 million in 2017 and is now projected to demonstrate a CAGR of 9.7% during the forecast period (2017-2025).
Get FREE Sample PDF Including COVID-19 Impact Analysis: https://www.coherentmarketinsights.com/insight/request-pdf/1255
Coagulation analyzers find extensive application in the diagnosis of bleeding disorders and thrombotic cases. These days, coagulation analyzers feature a fully automated infuse with several advanced features to perform various functions, such as cap piercing, primary tube sampling, dilution, and automatic rerun. These factors help reduce the total cost of the procedure, enhance the patient care quality, and assures regulatory compliance in the clinical laboratory. For instance, Instrumentation Laboratory, which is a product of Werfen Company, is designed for mid-to-high-volume clinical laboratories. The product offers the most advanced automation and quality management for routine, as well as specialty assays, including clotting, chromogenic, and immunological assays.
Browse Press Release: https://bit.ly/3kYkK9n
The key market players are deeply engaged in the development of next-generation diagnostic analyzers to help to improve specificity, accuracy, and productivity of these procedures. These innovative analyzers are known to offer extraordinary results in lesser turnaround time, which makes them highly feasible for the operators. For instance, in July 2017, Sysmex America, Inc. launched its XN-L automated hematology analyzers in the U.S. to meet the demand of lower-volume hematology analyzers. In 2014, Xprecia Stride Coagulation Analyzer, a product by Siemens Healthineers, received the U.S. FDA approval for reliable monitoring of oral anticoagulation therapy with warfarin, a vitamin K antagonist. Furthermore, in 2015, the product received the Red Dot award for its design quality. Therefore, such factors augment the growth of the global coagulation analyzers market.
Manufacturers are also implementing strategic acquisitions and collaborations to extend their product portfolios, besides launching new platform technologies. For instance, in January 2012, Roche entered into a strategic alliance with Technoclone to expand its reagent portfolio in coagulation diagnostics. This helped Roche strengthen its foothold in the field of in-vitro diagnostics. Furthermore, in August 2015, Abbott Laboratories entered into a definitive agreement to acquire Omnilab in a bid to expand its lab offerings to the international markets outside the U.S.
Special Requirements?
We value your investment and offer customization as per your requirements.
Share your precise requirements @ https://www.coherentmarketinsights.com/insight/request-customization/1255
Key Takeaways of the Global Coagulation Analyzers Market:
- Among the various product types, the clinical laboratory analyzers segment is expected to spearhead the global coagulation analyzers market over the projected period, primarily due to the burgeoning use of these devices in hospitals for the hematological analysis of patients.
- The prothrombin test segment accounted for the largest market fragment in 2016, owing to the increasing incidence of cardiovascular and blood related diseases worldwide. According to the Centers for Disease Control & Prevention (CDC), around 790,000 people in the U.S. suffer from heart attack annually, which indicates a potential need for immediate diagnosis and timely treatment in the country.
- The most prominent players operating in the global coagulation analyzers market are Siemens AG, Thermo Fisher Scientific Inc., Hoffmann-La Roche Ltd., Instrumentation Laboratory, Sysmex Corporation, Beckman Coulter, Inc. (Danaher), Diamond Diagnostics, International Technidyne Corporation, Nihon Kohden Corporation, and Alere Inc.
Apply Promo Code “STAYHOME” And Get an Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/1255
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
